PRGO

#2148
PERRIGO COMPANY PLC
11.4000 USD
+1.37%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
11.3600
11.4100
Rango anual
9.2250
22.0100
Cambio diario
+1.37%
Variación mensual
+20.57%
Variación en los últimos 6 meses
-47.03%
Cambio anual
-47.03%
Cierres anteriores
11.2460
Abrir
11.3600
Bid
Ask
Mínimo
11.3600
High
11.4100
Volumen
56
Ver el calendario completo

Financials

Visión general Informes Estadísticas Dividendos
Trimestre Año
  • Market Capitalization 1.5692 B
  • Employee 8 100
  • Founded N/A
  • CEO Murray S. Kessler
  • Website www.perrigo.com
  • Headquarter Ireland
  • FIGI N/A
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.35
Relación precio/flujo de caja
0.45
Dividendos por acción
1.16
Rendimiento por dividendo, %
8.33

Perrigo Company plc

Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park. Perrigo engages in the acquisition, manufacture, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients, primarily in the United States, from its base in Ireland. On 21 December 2018, Perrigo suffered its biggest one-day share price fall in its history after the Irish Revenue Commissioners issued a tax claim against Perrigo that equated to half of its market value.

Noticias